Company profile
Dragonfly Therapeutics, Inc.
- Industry
- Biotechnology Research
- Employees
- 32
- Headquarters
- Waltham, MA
- Founded
- 2016
- LinkedIn followers
- 15,457
- Office locations
- 1
Dragonfly Therapeutics, Inc. company summary
Dragonfly Therapeutics, Inc. is a company in the Biotechnology Research industry, headquartered in Waltham, MA, founded in 2016. On LinkedIn the company has around 32 employees and 15,457 followers. Its listed specialties include immuno-oncology.
What technology does Dragonfly Therapeutics, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Dragonfly Therapeutics, Inc.
Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to harness the body's immune system to bring breakthrough treatments to patients. In addition to its wholly owned clinical assets, Dragonfly has a deep pipeline of wholly owned preclinical candidates discovered using its proprietary platform, as well as productive collaborations with Merck, AbbVie, Gilead and Bristol Myers Squibb in a broad range of disease areas. For more information, email info@dragonflytx.com.
Specialties
Where is Dragonfly Therapeutics, Inc. located?
Dragonfly Therapeutics, Inc. lists 1 location.
Compare companies similar to Dragonfly Therapeutics, Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Dragonfly Therapeutics, Inc. dragonflytx.com | Biotechnology Research | 32 | 2016 | Waltham, MA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Dragonfly Therapeutics, Inc.
What does Dragonfly Therapeutics, Inc. do?
Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to harness the body's immune system to bring breakthrough treatments to patients. In addition to its wholly owned clinical assets, Dragonfly has a deep pipeline of wholly owned preclinical candidates discovered using its proprietary platform, as well as productive collaborations with Merck, AbbVie, Gilead and Bristol Myers Squibb in a broad range of disease areas. For more information, email info@dragonflytx.com.
How many employees does Dragonfly Therapeutics, Inc. have?
Dragonfly Therapeutics, Inc. has around 32 employees on LinkedIn.
Where is Dragonfly Therapeutics, Inc. headquartered?
Dragonfly Therapeutics, Inc. is headquartered in Waltham, MA.
When was Dragonfly Therapeutics, Inc. founded?
Dragonfly Therapeutics, Inc. was founded in 2016.
Build a lead list from companies like Dragonfly Therapeutics, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.